Can permanent birth control move into the OB-GYN office? FemBloc gets a clearer FDA pathway.
FDA has agreed to Femasys’ modular PMA approach for FemBloc, allowing manufacturing and nonclinical portions to be reviewed before the pivotal FINALE pregnancy data are complete.